Posts filtered by tags: Moderna[x]


 

Booster Doses are Powerful, May Fight Omicron, Researchers Find

Last week researchers at Northwestern University calculated that one week after a Covid-19 booster shot, median antibody levels were 23 times higher than before the shot. This Thursday the Times of London reported that another study found similar results: Booster jabs "massively" strengthen the body's defences against Covid, according to key results that have raised hopes of strong protection from the Omicron variant. A third dose not only increased antibody levels thirtyfold, but roughly tri...
Tags: Tech, Fda, Pfizer, Business Insider, Northwestern University, Hill, Johnson Johnson, Faust, The Hill, Times of London, Scott Gottlieb, Moderna, Omicron, Albert Bourla, Bourla, COVID


Pfizer said it expects to have more data by end of year on whether COVID-19 vaccine can be administered to children under 5

Carlo Allegri/Reuters Pfizer CEO Albert Bourla on Friday said there will be more data on children under five receiving a COVID-19 vaccine by the end of the year. Pfizer has begun pediatric vaccine trials. Moderna and Johnson & Johnson are also planning to conduct trials.  Pfizer's announcement comes as the new Omicron variant begins to spread in the United States. Pfizer CEO Albert Bourla on Friday said the company expects to know more about the effectiveness of its vaccines in children u...
Tags: Health, Science, News, US, Trends, United States, Pfizer, Vaccines, Anthony Fauci, Johnson Johnson, Fauci, Moderna, Stéphane Bancel, Omicron, Albert Bourla, Bourla


Evaluating comparative effectiveness of Pfizer-BioNtech and Moderna vaccines among US veterans

A new study provided evidence of a lower 24-week risk of COVID-19–related outcomes among recipients of the mRNA-1273 vaccine, compared to their counterparts who received the BNT162b2 vaccine.
Tags: Health, US, Moderna, Pfizer BioNTech


Pfizer and Moderna give best overall boost - UK trial

Researchers say there are signs the boosters would still offer protection against new variant Omicron.
Tags: UK, News, Pfizer, Moderna


Covid: Pfizer and Moderna jabs give best overall boost, UK trial finds

Researchers also say there are signs the boosters would still offer protection against new variant Omicron.
Tags: UK, News, Pfizer, Moderna


New testing requirements for US-bound travelers will take effect Monday

• Germany announces lockdown for unvaccinated • Watch: Moderna president clarifies CEO's remarks on vaccine's efficacy against Omicron • What to know about travel changes prompted by Omicron
Tags: News, Germany, US, Stories, Moderna


Vaccines are the key. They're also making some people very rich.

The US government has put billions of dollars into developing and producing Covid-19 vaccines, but it doesn't own them. Taxpayers are now paying Pfizer and Moderna billions for the vaccines.
Tags: US, Cnn, Pfizer, Moderna


How to choose which booster shot is right for you, between Pfizer and Moderna

Vials of the Moderna (R) and Pfizer (L) COVID-19 vaccines.Hazem Bader/AFP via Getty Images Most people who've gotten booster shots in the US have stuck with the same brand of vaccine they had initially. But, it's also fine to switch it up. Some early studies suggest that Moderna's vaccine is slightly stronger than Pfizer's. "To be honest, I'm not sure there's really a big difference between those two," one expert said. Now that free booster shots are being offered to a...
Tags: Science, News, US, Trends, Public Health, Pfizer, Anthony Fauci, Johnson Johnson, J J, Johns Hopkins University, R, International Vaccine Access Center, L, Moderna, William Moss, Hilary Brueck


COVID Patents at the Federal Circuit (Moderna Loses)

by Dennis Crouch Moderna Therapeutics v. Arbutus BioPharma (Fed. Cir. 2021) (20-1184 Decision) (20-2329 Decision) Arbutus owns several patents related to a lipid-based delivery system for nucleic-acid-based treatments.  U.S. Patent 8,058,069 and 9,364,435 are the two at issue here. The claims are directed to the creation of a “acid-lipid particle” that includes some RNA along with lipids to stabilize the sequence, including particular percentages of cationic lipids, non-cationic lipids, and conj...
Tags: Law, Pfizer, Patent, Federal Circuit, IPR, Moderna, Protiva, Arbutus, Federal Circuit Moderna, Dennis Crouch Moderna Therapeutics, Arbutus BioPharma Fed


Pfizer or Moderna? Head-to-Head Study Shows One Shot Has an Edge

By Robert Preidt, HealthDay ReporterTHURSDAY, Dec. 2, 2021 (HealthDay News) -- Which coronavirus vaccine is best at beating COVID-19 -- Moderna or...
Tags: Moderna, Robert Preidt HealthDay


Dr. Fauci tackles Omicron questions

• LIVE UPDATES Moderna president hopes vaccine will 'hold up quite well' against Omicron • US confirms first Omicron case • TV personality who pushed fabricated Covid claims running for Senate
Tags: News, US, Stories, Fauci, Moderna


Moderna president clarifies CEO's remarks on vaccine's efficacy against Omicron

During a CNN Global Town Hall, Moderna President Stephen Hoge responded to comments from the company's CEO Stéphane Bancel in which he suggested that current vaccines might struggle with the Omicron variant.
Tags: News, Stories, Moderna, Stéphane Bancel, Stephen Hoge, CNN Global Town Hall Moderna


Stocks dive at the close as first confirmed US Omicron case triggers sharp reversal

The New York Stock Exchange.Photo by Spencer Platt/Getty Images Stocks turned sharply lower Wednesday after the US identified a case of Omicron in California.  The S&P 500 had been on course to recover from Tuesday's nearly 2% rout.  Stocks were up earlier in the day after a better-than-expected jobs report from ADP. US stocks retreated from earlier gains to finish sharply lower Wednesday, after US officials said the country now has its first case of a person with the Omicron coronavirus ...
Tags: California, Cdc, US, Trends, Markets, Opec, South Africa, Stocks, New York Stock Exchange, Jack Dorsey, Centers For Disease Control And Prevention, S&P 500, Dow Jones Industrial Average, ADP, Nasdaq Composite, Labor Department


US stocks dive at the close as first confirmed US Omicron case triggers sharp reversal

The New York Stock Exchange.Photo by Spencer Platt/Getty Images Stocks turned sharply lower Wednesday after the US identified a case of Omicron in California.  The S&P 500 had been on course to recover from Tuesday's nearly 2% rout.  Stocks were up earlier in the day after a better-than-expected jobs report from ADP. US stocks retreated from earlier gains to finish sharply lower Wednesday, after US officials said the country now has its first case of a person with the Omicron coronavirus ...
Tags: California, Cdc, US, Trends, Markets, Opec, South Africa, Stocks, New York Stock Exchange, Jack Dorsey, Centers For Disease Control And Prevention, S&P 500, Dow Jones Industrial Average, ADP, Nasdaq Composite, Labor Department


Omicron-specific vaccine testing underway: Moderna chairman responds to first omicron variant detected in US

Moderna chairman Noubar Afeyan joins 'The Claman Countdown' to discuss the first omicron case in the U.S and how his company is responding to it. #theclamancountdown #noubarafeyan
Tags: US, Claman, Noubar Afeyan, Moderna


Moderna drops, Arbutus pops after patent ruling means vaccine maker could owe royalties on billions in COVID shot revenue

Traders have been cheered by earnings but are still concerned about inflation.Brendan McDermid/Reuters Moderna stock fell 11% on Wednesday after the vaccine maker lost a patent fight against Arbutus Biopharma.Arbutus jumped 103% following the ruling as it could lead to royalty payments from Moderna.Moderna's COVID-19 vaccine is expected to generate about $20 billion in revenue this year and next.Moderna stock tanked as much as 11% on Wednesday after the drugmaker lost a patent fight agains...
Tags: Trends, Markets, Stock Market, US Patent And Trademark Office, Jefferies, Reuters, Matthew Fox, Moderna, Arbutus Biopharma, Moderna Moderna, Mover, Covid Vaccine, Moderna stock, Moderna stock price, MRNA stock, Stock Market 2021


The S&P 500 is headed for 12 straight months of record highs for the first time in 7 years — if Omicron doesn't wreck the streak, says LPL

Traders work on the floor of The New York Stock ExchangeSpencer Platt/Getty Images The S&P 500 in December could notch 12 straight months of record highs, matching a streak only seen in 2014.  LPL Financial said worries about the Omicron coronavirus variant could halt the monthly run of new records.   The S&P 500 gave up gains Wednesday as the first US Omicron case was confirmed.  The S&P 500 could mark 12 consecutive months of notching a new record high, but worries about the Omicron coronav...
Tags: California, US, Trends, Markets, Stocks, S&P 500, LPL, Carla Mozee, Moderna, LPL Financial, Detrick, Ryan Detrick, Stock Market News, MI Exclusive, S&P 500 record highs 2021, Stock Market Record Highs 2021


Current COVID-19 vaccines likely won't work as well against Omicron variant, Moderna's CEO says

Drugmaker executive predicts a "material drop" in the efficacy of existing vaccines against the new variant. #omicron #drugmakerexecutive #moderna
Tags: Moderna


Hedge fund titan Ray Dalio warns investors against trying to time the market as Omicron rocks stocks

The 'king of hedge funds' Ray Dalio had a nightmarish 2020Kimberly White/Getty Images Hedge fund boss Ray Dalio warned against trying to time the market as Omicron causes volatility. He said it's important to be invested in a balanced portfolio and cautioned against holding cash. Dalio also said money printing doesn't raise living standards in the economy, but said productivity is key. Legendary investor Ray Dalio has warned people against trying to time the market as uncertai...
Tags: US, Trends, World Health Organization, Federal Reserve, Cnbc, Andrew Ross Sorkin, Ray Dalio, Dalio, Moderna, BlackRock Investment Institute, Harry Robertson, Omicron, Bridgewater Associates the world, Jean Bovin


Most Gulf bourses rebound after virus-fuelled rout | Reuters

Most Gulf bourses rebound after virus-fuelled rout | Reuters Most stock markets in the Gulf rose in early trade on Wednesday, rebounding from a sell-off triggered by comments from Moderna's chief executive that existing COVID-19 vaccines would be less effective against the new Omicron variant.Saudi Arabia's benchmark index (.TASI) rose 0.7%, with Al Rajhi Bank (1120.SE) advancing 2.1% and petrochemical maker Industries Qatar (IQCD.QA) putting on 1.3%.Elsewhere, Fawaz Abdulaziz Alhokair (4240.S...
Tags: Travel, Saudi Arabia, Russia, Eu, Opec, Qatar, United Arab Emirates, Reuters, Petroleum Exporting Countries OPEC, Tasi, Rupert Neil Bumfrey, Moderna, Al Rajhi Bank, Masraf Al Rayan, Fawaz Abdulaziz Alhokair, Industries Qatar IQCD


US stock futures rebound from another Omicron sell-off despite Jerome Powell hawkishness

Investors have to brace for more market volatility thanks to the new Omicron variant.Xinhua News Agency/Getty Images US futures rallied Wednesday, and European stocks rebounded from the latest Omicron sell-off. Investors were digesting Fed Chair Jerome Powell's comments on inflation no longer being transitory and an earlier end to tapering. The S&P 500 closed Tuesday 2.9% below its record level, which was reached in November. US stock futures rallied Wednesday as global stocks rebounded f...
Tags: Hong Kong, US, Trends, Treasury, Tokyo, US Treasury, University of Oxford, Dow Jones, Financial Times, Fed, Powell, Federal Reserve Chair, Jerome Powell, LPL, Moderna, OANDA


Moderna's CEO says current COVID-19 vaccines likely won't work as well against Omicron

Drugmaker executive predicts a "material drop" in the efficacy of existing vaccines against the new variant. #omicrondrugmaker #drugmakerexecutive
Tags: Moderna


Dow falls 652 points on Fed chief Powell's tapering comments and Omicron variant concerns

US stocks looked set to rally on Monday.Spencer Platt/Getty Images US stocks tumbled Tuesday after tapering comments from Fed Chair Jerome Powell stoked rate-hike fears. Investors' nerves were already rattled after Moderna's CEO expressed reservations about the efficacy of the company's vaccine against the new strain. The 10-year Treasury note yield slid to 1.444% from Monday's 1.529%. Sign up here for our daily newsletter, 10 Things Before the Opening Bell US stocks tumbled T...
Tags: US, Trends, Treasury, World Health Organization, Financial Times, Fed, Jpmorgan, Powell, Petroleum Exporting Countries, Federal Reserve Chair, Jerome Powell, Moderna, OANDA, Grayscale Investments, Stéphane Bancel, Omicron


U.S. oil prices slump over 5% on vaccine efficacy worries | Reuters

U.S. oil prices slump over 5% on vaccine efficacy worries | Reuters Oil prices tumbled on Tuesday, with U.S. crude futures falling by more than 5%, after Moderna's chief cast doubt on the efficacy of COVID-19 vaccines against the Omicron coronavirus variant, spooking financial markets and heightening worries about oil demand.The head of drugmaker Moderna Inc (MRNA.O) told the Financial Times that COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus a...
Tags: Travel, Wti, Financial Times, Reuters, Reuters Oil, Rupert Neil Bumfrey, Moderna, Moderna INC MRNA


Oil falls on vaccine efficacy worries; WTI down over 6% | Reuters

Oil falls on vaccine efficacy worries; WTI down over 6% | Reuters Oil prices tumbled on Tuesday, with U.S. crude futures falling by more than 6%, after Moderna's chief cast doubt on the efficacy of COVID-19 vaccines against the Omicron coronavirus variant, spooking financial markets and heightening worries about oil demand.The head of drugmaker Moderna Inc (MRNA.O) told the Financial Times that COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as ...
Tags: Travel, Japan, Australia, Financial Times, Reuters, Reuters Oil, Rupert Neil Bumfrey, Moderna, Louise Dickson, Moderna INC MRNA, Rystad Energy Another


Adagio Therapeutics extends 3-day gain to 319% on hopes that its antiviral can treat the Omicron variant

A stock trader claps at the end of trade at the New York Stock Exchange.EMMANUEL DUNAND/AFP via Getty Images Adagio Therapeutics stock is up as much as 319% since the Omicron variant of COVID-19 was identified last week.Adagio said it believes its antibody drug candidate, ADG20, will be effective against the new strain. The company is anticipating emergency use authorization for its drug in the second half of 2022.Adagio Therapeutics stock soared as much as 68% on Tuesday, extending its three-...
Tags: Finance, Trends, Markets, Trading, Fda, Stock Market, Morgan Stanley, Financial Times, Adagio, Waltham, Laura Walker, Matthew Fox, Moderna, Matthew Harrison, Stéphane Bancel, Tillman Gerngross


The yield on the key 10-year Treasury is tumbling as investors flee to safe haven assets in the face of Omicron worries

Federal Reserve Chairman Jerome PowellPool/ Getty Images Bond yields sharply dropped Tuesday on worries that Omicron may be a vaccine-resistant strain of coronavirus.  The 30-year Treasury yield fell to its lowest level in 10 months and the 10-year yield hit a three-week low.  Fed Chairman Jerome Powell warns of downside economic risks from the new virus variant. Investors pushed into US government bonds Tuesday, driving down yields as they looked for shelter from warnings about the Omicron v...
Tags: US, Trends, Markets, Treasury, Capitol Hill, Federal Reserve, Financial Times, Fed, Powell, Jerome Powell, Carla Mozee, Moderna, Stéphane Bancel, Bancel, COVID, Bond Yields


The rise in the S&P 500 won't be stopped by the Omicron variant and the benchmark will hit 5,050 by the end of next year, JPMorgan says

The New York Stock Exchange.Photo by Spencer Platt/Getty Images The rise in the S&P 500 will not be hampered by the emergence of the Omicron variant, JPMorgan analysts said. Seeming threats such as the new strain should be seen as "sporadic setbacks," they added. Instead, they view a hawkish shift in the Fed's policy as a key risk to their outlook. Sign up here for our daily newsletter, 10 Things Before the Opening Bell The rise in the S&P 500 will not be hampered by the emergence of the ...
Tags: China, US, Trends, World Health Organization, New York Stock Exchange, Federal Reserve, Financial Times, Fed, Jpmorgan, JPMorgan Chase, Spencer Platt Getty Images, Moderna, Dubravko Lakos Bujas, Omicron, Isabelle Lee, Omicron US


Moderna CEO Says Vaccines Likely Less Effective Against Omicron

The head of drugmaker Moderna said COVID-19 vaccines are unlikely to be as effective against the Omicron variant of the coronavirus as they have been previously, sparking fresh worry in financial markets about the trajectory of the pandemic. From a report: "There is no world, I think, where (the effectiveness) is the same levelâ... we had with Delta," Moderna Chief Executive Stéphane Bancel told the Financial Times in an interview. "I think it's going to be a material drop. I just don't know ho...
Tags: Tech, Financial Times, Cnbc, Moderna, Bancel, COVID, Delta Moderna


US stocks extend losses as new tapering comments from Fed Chair Powell stoke rate-hike concern

New York Stock Exchange on Aug. 19, 2021.Wang Ying/Xinhua via Getty Images US stocks extended earlier losses on Tuesday after tapering comments from Fed Chair Jerome Powell stoked rate-hike fears. Investor nerves were already rattled after Moderna's CEO expressed reservations about the efficacy of his vaccine against the new strain. The 10-year Treasury note yield slid. Sign up here for our daily newsletter, 10 Things Before the Opening Bell US stocks extended earlier losses on Tuesday fo...
Tags: US, Trends, Gold, Markets, Treasury, World Health Organization, Brent Crude, S&P, New York Stock Exchange, Nasdaq, Anthony Fauci, Dow Jones, Gold Price, Financial Times, S&P 500, Dow Jones Industrial Average